The global Thrombin Inhibitor market is estimated to be valued at US$ 1.86 billion in 2023 and is expected to exhibit a CAGR of 5.8% over the forecast period 2023-2030, as highlighted in a… Read More

The anticoagulants market size is poised to grow by $ 70 billion by 2030 from $ 34.91 billion in 2022, exhibiting a CAGR of 9.09% during the forecast period 2022-2030. The Anticoagulants ma… Read More

“Anticoagulant Reversal Drugs Market” study by “The Insight Partners” provides details about the market dynamics affecting the market, Market scope, Market segmentati… Read More

The Global Anticoagulants Drug Market is highly fragmented due to the presence of a various large number of players which forms a competitive environment. The report entails all-inclusive in… Read More

Our Latest Anticoagulant Reversal Drugs Market Report offers a complete picture of industry trends and factors along with quantitative data based on historical data and from various sources… Read More

The Anticoagulants Market is expected to register a CAGR of 9.41% during the forecast period. Anticoagulants are used to treat and prevent blood clots which can block blood vessels (an arter… Read More

The Anticoagulants Market is expected to register a CAGR of 7.6% during the forecast period. Anticoagulants are used to treat and prevent blood clots which can block blood vessels (an artery… Read More

The report predicts the global US Anticoagulation Therapy Market to grow at a healthy CAGR over the forecast period from 2022-2031. “The US anticoagulation therapy market projected… Read More

New York, New York--(Newsfile Corp. - February 6, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Portola Pharmaceuticals, Inc. (NASDAQ: PTLA)… Read More

According to the new market research report ” US Anticoagulation Therapy Market by Product ((Anticoagulants Drugs (NOACs, Warfarin)), PT/INR Devices (In-Office, Home Testing)), Se… Read More

Read More

"This acquisition is particularly exciting as it immediately diversified our commercial stage portfolio and provided the opportunity to apply our demonstrated global commercial excellence,"… Read More

Transparency Market Research (TMR) (www.transparencymarketresearch.com) has published a new report titled, “Anticoagulant Reversal Drugs Market – Global Industry Analysis, Size… Read More

C. H. Boehringer Sohn (Germany), Bristol-Myers Squibb (US), Johnson & Johnson (US), Pfizer (US), Daiichi Sankyo (Japan), and Portola Pharmaceuticals (US) are the major market players in… Read More

The Covid-19 pandemic of 2020 has thrust the pharmaceutical and biotech industry centerstage with almost all the major players in the industry engaged in coming up with a solution to the Cor… Read More

Buy Now Anticoagulant drugs are medicines that has application in protection from blood coagulation, accustomed to reverse or balance haemorrhage. It conjointly helpful in prevention of risk… Read More

Anticoagulant Reversal Drugs Market Expected To Exhibit Double Digit Growth During The Forecast Period The latest market report published by Credence Research, Inc. “Anticoagulants Re… Read More

SAN FRANCISCO, Dec. 06, 2018 (GLOBE NEWSWIRE) — Eidos Therapeutics, Inc. (Eidos) (Nasdaq:EIDX), a clinical stage biopharmaceutical company focused on addressing the large unmet need in… Read More

Xarelto (rivaroxaban) blocks the activity of certain clotting substances in the blood. Xarelto is used to prevent or treat a type of blood clot called deep vein thrombosis (DV… Read More